Under ideal conditions, grain storage options in India are built up from the buffer stock strategies. These, in turn, are derived from fluctuations in grain output and the need to ride through, say, two bad years. To the needs of the required buffer are added the demands from operational requirements and those of grains in transit. Once upon a time, there used to be controversies concerning why should we separately account...

KEY TRENDS   • Maternal Mortality Ratio for India was 370 in 2000, 286 in 2005, 210 in 2010, 158 in 2015 and 145 in 2017. Therefore, the MMRatio for the country decreased by almost 61 percent between 2000 and 2017 *14    • As per the NSS 71st round, among rural females aged 5-29 years, the main reasons for dropping out/ discontinuance were: engagement in domestic activities, not interested in education, financial constraints and marriage. Among rural males aged...

KEY TRENDS   • Section 105 of the Right to Fair Compensation and Transparency in the Land Acquisition, Rehabilitation and Resettlement Act, 2013, which provides for excluding 13 Central legislation, including Land Acquisition (Mines) Act 1885, Atomic Energy Act, 1962, Railway Act 1989, National Highways Act 1956 and Metro Railways (Construction of Works) Act, 1978, from its purview, has been amended for payment of compensation with rigours $ • The amendments have now...

Exaggeration. Exaggeration. Exaggeration.  I was subjected to this tiresome litany from various angry officials and a couple of politicians after one of their colleagues — who will remained unnamed — leaked to me the perilous state of India’s granaries and the rotting foodgrain within. On July 26, I reported how 50,000 metric tonnes of wheat and rice had rotted away, unfit even for animals; how 17.8 million tonnes, enough to feed...

No clarity on which authorities will be competent or which laws will be relevant: Ramesh He agrees with the compromise of Department of S&T as the nodal Ministry The Biotechnology Regulatory Authority of India (BRAI) will only deal with the safety and efficacy aspects of biotech products, leaving the controversial commercialisation aspect hanging in the air, according to the latest version of the BRAI Bill, 2010. The Bill, which was supposed to be...